AVITA Medical, Inc.
RCEL
$9.91
-$0.15-1.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 27.78% | 8.69% | 11.88% | -32.93% | 28.42% |
| Total Depreciation and Amortization | -3.51% | -3.09% | 12.72% | 3.99% | 5.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.22% | 48.00% | -77.52% | 594.18% | -66.71% |
| Change in Net Operating Assets | 153.79% | -155.29% | 323.84% | 153.21% | -842.32% |
| Cash from Operations | 65.29% | -85.22% | -4.20% | 48.98% | 0.78% |
| Capital Expenditure | -468.42% | -102.82% | 172.16% | -78.24% | -137.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 94.03% | 410.71% | 84.96% | -158.45% | -31.37% |
| Cash from Investing | 90.54% | 18,454.55% | 100.21% | -176.13% | -34.83% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -98.33% | 2,551.88% | 53.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | -92.83% | 2,358.47% | -98.20% | 2,362.61% | 53.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 142.92% | 62.66% | -261.54% | 220.80% | -423.66% |